<unk>  <unk>  utilizes an antibody labeled with a radionuclide to deliver cytotoxic radiation to a target cell.  In cancer therapy, an antibody with specificity for a tumor-associated antigen is used to deliver a lethal dose of radiation to the tumor cells.  The ability for the antibody to specifically bind to a tumor-associated antigen increases the dose delivered to the tumor cells while decreasing the dose to normal tissues.  By its nature,<unk>  requires a tumor cell to express an antigen that is unique to the neoplasm or is not accessible in normal cells.
Radioimmunotherapy
CyBorD regimen
R-EPOCH regimen
External beam radiotherapy
Targeted therapy
R-CHOP regimen
DA-R-EPOCH regimen
VR-CHOP regimen